How many deaths were expected from background mortality during the COVID-19 vaccine rollout?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Early in the U.S. COVID‑19 vaccine rollout, passive surveillance captured dozens of deaths reported after vaccination but independent analyses found those numbers were far smaller than the deaths expected just by background mortality. For example, one early VAERS analysis identified 55 deaths among 6.7 million vaccinated people (≈8.2 per million) through Jan 8, 2021, and authors emphasized that crude rates after vaccination were lower than expected all‑cause death rates in the general population [1] [2].
1. What "background mortality" means — and why it's central
Background mortality refers to the number of deaths you would expect to see in a population over a given interval regardless of vaccination; when millions are vaccinated in a short window, some people will die soon afterward by coincidence. Studies that examined deaths reported after COVID‑19 vaccination explicitly compared observed post‑vaccine reports to expected all‑cause death rates to avoid mistaking coincidence for causation [1] [2].
2. Early post‑rollout reports: raw counts from VAERS and early studies
A peer‑reviewed early study that searched VAERS from Dec. 11, 2020 to Jan. 8, 2021 found 55 deaths among 6,688,231 vaccinated people, giving a crude mortality rate of 8.2 per million for that period; among long‑term‑care residents the rate was higher in that dataset (53.4 per million) [1]. A later review using broader timeframes estimated crude rates such as 3.24 deaths per 100,000 within 60 days in some analyses, and authors noted those crude reported rates were substantially lower than expected all‑cause death rates over comparable windows [2].
3. Why numbers reported to VAERS do not equal vaccine‑caused deaths
Journalists and public health officials repeatedly caution that VAERS is a passive, open reporting system where reports are not verified and do not establish causation; the mere fact that a death occurred following vaccination does not mean the vaccine caused it. Early papers and reviews emphasized using expected background death rates and formal epidemiologic methods to determine whether observed post‑vaccine deaths exceeded what would be expected by chance [1] [2].
4. Later, larger studies did not find increased all‑cause mortality after mRNA vaccination
Large cohort analyses from other countries have not observed increased long‑term all‑cause mortality after mRNA vaccination. A nationwide French cohort that followed adults up to four years found no signal of higher mortality; instead, vaccinated adults showed lower risks of death from severe COVID‑19 and lower all‑cause mortality after adjustment for many confounders (reported as a 74% lower risk of severe‑COVID death and roughly 25% lower all‑cause mortality before adjustment) [3] [4]. Media coverage summarized that investigators found no evidence of increased long‑term mortality linked to mRNA vaccination [4].
5. Conflicting claims and a recent controversy over child deaths
A high‑profile internal FDA memo and reporting by Reuters and others stated the agency’s chief medical and scientific officer concluded that "no fewer than 10" child deaths were related to COVID‑19 vaccination, based on an initial review of 96 deaths from 2021–2024; the memo reportedly cited heart‑inflammation among potential mechanisms but provided few public details [5] [6]. That claim sits alongside multiple public health statements asserting population‑level data show no detectable increase in mortality after mRNA vaccines — a direct conflict that prompted media scrutiny [7] [6] [5].
6. How experts reconcile the discrepancy: investigation, transparency, and methods matter
Investigators and reporters note differences in methodology: passive reports vs. validated case reviews, small case series vs. population‑scale cohort studies, and the need to control for confounding (healthy‑vaccinee effects, frailty, undiagnosed COVID). Public‑facing analyses emphasized that if vaccines did cause deaths, the frequency would be so low as to be statistically undetectable in population studies — but the FDA memo suggests internal case reviews found a small number of possibly related pediatric deaths, a claim for which broader public documentation was not available in the cited sources [1] [2] [7] [5].
7. What is and isn’t documented in available reporting
Available sources document early VAERS counts (55 deaths among 6.7 million in one early study) and larger cohort analyses finding no increase in all‑cause mortality and even net mortality reductions in vaccinated adults [1] [4]. Available sources do not present a public, peer‑reviewed analysis that confirms the FDA memo’s claim that at least 10 child deaths were caused by vaccination; the memo and Reuters reporting describe the agency’s internal conclusion but provide limited methodological detail in public reporting [5] [6].
8. Bottom line for readers: context, not panic
When assessing whether vaccines “caused” deaths, the relevant benchmark is expected background mortality and rigorous epidemiologic investigation, not raw counts from passive systems. Early VAERS counts were small relative to the numbers vaccinated and, in published cohort data, post‑vaccine mortality did not exceed expected background levels — though recent internal FDA statements about pediatric cases demand transparent, public follow‑up so independent researchers can evaluate methods and conclusions [1] [2] [5] [4].